Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Merkel Cell × Surgical Procedures, Operative × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 55 Rectal Neoplasms 46 Breast Neoplasms 39 Stomach Neoplasms 34 Esophageal Neoplasms 34 Colorectal Neoplasms 29 Lung Neoplasms 26 Brain Neoplasms 22 Pancreatic Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 20 Neoplasms 19 Sarcoma 18 Glioblastoma 18 Neoplasm Metastasis 17 Carcinoma, Hepatocellular 16 Head and Neck Neoplasms 15 Esophageal Squamous Cell Carcinoma 15 Glioma 13 Recurrence 11 Colonic Neoplasms 11 Oropharyngeal Neoplasms 10 Adenocarcinoma Of Esophagus 10 Ovarian Neoplasms 9 Melanoma 9 Thyroid Neoplasms 8 Prostatic Neoplasms 8 Laryngeal Neoplasms 8 Hypopharyngeal Neoplasms 8 Astrocytoma 8 Central Nervous System Neoplasms 7

Interventions

pembrolizumab 12 avelumab 8 Radiotherapy 8 Nivolumab 7 cemiplimab 4 Radiation 4 Ipilimumab 4 poly ICLC 3 atezolizumab 3 Cyclophosphamide 3 talimogene laherparepvec 2 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Interferon-beta 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2 Biopsy 2 veliparib 1 vatalanib 1 tremelimumab 1 tocilizumab 1 temsirolimus 1 sargramostim 1 sapanisertib 1 relatlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05253144 2024-05-08

Rational-MCC

University of Birmingham

Phase NA Completed

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡